Hill-Rom Holdings: stocks, financial statements

Dividends News
Favorites

Hill-Rom Holdings, Inc. is a medical technology company, which focuses on patient care solutions that improve clinical and economic outcomes. It operates through the following business segments: Patient Support System, Front Line Care, and Surgical Solutions. The Patient Support Systems segment provides bed frames and surfaces, mobility, and clinical workflow solutions. The Front Line Care segment offers respiratory care products; and sells medical diagnostic equipment and a diversified portfolio of devices. The Surgical Solutions segment supplies surgical products including tables, lights, pendants, positioning devices, various other surgical products, and accessories. The company was founded by William A. Hillenbrand on August 7, 1969 and is headquartered in Chicago, IL.

  • HRC Ticker
  • NYSE Exchange
  • 10,000 Employees
3 rated
  • $112.27, $-0.34 (-0.30%) Previous Close
  • 619,697 Previous Volume
  • $79.77 / $117.42 52 week low / high
  • -4.10% Percent off 52 week high
  • 2021-06-18 Updated
  • 0.61% Dividend Yield (trailing)
  • 0.86% Dividend Yield (forward)
  • 0 Public float
  • 66,465,612 Outstanding shares
  • 26.52 P/E
  • 7.48 B Market Cap
Disable ads for free

Financial statements — Hill-Rom Holdings

The information is not 100% up-to-date. There may be errors or missing information. Some information is often missing, and, although there are almost no errors, I can't rule them out. Right now, I'm looking for a supplier of high-quality information, but so far what I'm finding is expensive (about $2000 a year). You can help my project here.
20 ← 16 2020 2019 2018 2017 2016
Total Revenue
2.9B 2.9B 2.8B 2.7B 2.7B
Cost Of Revenue
1.4B 1.5B 1.5B 1.4B 1.4B
Gross Profit
1.5B 1.4B 1.4B 1.3B 1.3B
Research and Development
140M 140M 140M 130M 130M
Selling General and Admin
820M 940M 890M 880M 850M
Operating Expense
2.5B 2.6B 2.5B 2.4B 2.4B
Operating Income
410M 340M 370M 310M 270M
Other Income Expense Net
0 0 0 0 0
EBIT
410M 340M 370M 310M 270M
Interest Income
74M 90M 95M 89M 90M
Pretax Income
270M 210M 200M 180M 140M
Income Tax
48M 56M -55M 51M 16M
Minority Interest
0 0 0 -1.3M -1.3M
Net Income
220M 150M 250M 130M 120M
Net Income Basic
220M 150M 250M 130M 120M
20 ← 16 2020 2019 2018 2017 2016
Current cash
300M 210M 180M 230M 230M
Short term investments
120M 110M 100M 71M 83M
Receivables
590M 650M 580M 580M 520M
Inventory
350M 270M 290M 280M 250M
Other current assets
120M 110M 100M 71M 83M
Current assets
1.4B 1.7B 1.2B 1.2B 1.1B
Long term investments
3.3B 3.3B 3.2B 3.4B 3.2B
Property plant equipment
310M 300M 330M 360M 350M
Goodwill
1.8B 1.8B 1.7B 1.8B 1.6B
Intangible assets
980M 1B 1B 1.1B 1.1B
Other assets
160M 91M 75M 63M 60M
Total assets
4.7B 4.9B 4.4B 4.5B 4.3B
Accounts payable
240M 200M 180M 170M 140M
Current long term debt
220M 660M 180M 190M 210M
Other current liabilities
490M 410M 300M 300M 320M
Total current liabilities
950M 1.3B 660M 660M 660M
Long term debt
1.7B 1.8B 1.8B 2.1B 1.9B
Other liabilities
220M 150M 110M 120M 140M
Minority Interest
0 0 0 7.4M 8.7M
Total Liabilities
2.9B 3.3B 2.7B 3.2B 3B
Common stock
67M 67M 66M 66M 65M
Retained earning
2.1B 2B 1.9B 1.7B 1.6B
Treasury stock
-900M -850M -750M -800M -770M
Capital surplus
Shareholder equity
1.7B 1.6B 1.6B 1.4B 1.2B
Net tangible assets
-1.1B -1.3B -1.1B -1.5B -1.5B
20 ← 16 2020 2019 2018 2017 2016
Net Income
220M 150M 250M 130M 120M
Depreciation
180M 190M 200M 100M 110M
Changes in receivables
-58M 73M 1.4M 64M 20M
Changes in inventories
82M -22M 7.2M 33M -15M
Cash change
82M 31M -49M -400K 39M
Cash flow
-480M 400M 400M 310M 280M
Capital expenditures
-110M -73M -90M -98M -83M
Investments
Investing activity other
Total investing cash flows
-130M -250M -82M -390M -98M
Dividends paid
Net borrowings
1.5B 2.1B 1.7B 2B 1.8B
Other financing cash flows
Cash flow financing
-700M 300M -360M 71M -140M
Exchange rate effect